ADC Therapeutics SA — Director's Dealing 2025

Jun 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADC Therapeutics SA (ADCT)
CIK: 0001771910
Period of Report: 2025-06-03

Reporting Person: Squarer Ron (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-03	Common Shares	A	40000	—	Acquired	108811	Direct

Footnotes

F1: Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's
continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.